Lung cancer statistics
Smoking is the principal cause of lung cancer; it is estimated to be responsible for 85 per cent of all types of this cancer.
The Second Expert Report Panel judged that there was convincing evidence that arsenic in drinking water and beta-carotene supplements increase the risk of lung cancer. Consuming fruits, and also foods containing carotenoids, probably protect against this cancer.
The countries with the top 20 highest incidence of lung cancer in 2012 are given in the tables below.
Both sexes
- Hungary had the highest rate of lung cancer, followed by Serbia and Democratic Republic of Korea.
- About 58 per cent of lung cancer cases occurred in less developed countries.
- The highest incidence of lung cancer was in Northern America and Europe; and the lowest incidence in Africa and, Latin America and Caribbean.
Rank | Country | Age-Standardised Rate per 100,000 (World) |
---|---|---|
1 | Hungary | 51.6 |
2 | Serbia | 45.6 |
3 | Korea, Democratic Republic of | 44.2 |
4 | FYR Macedonia | 40.8 |
5 | New Caledonia | 40.1 |
6 | Montenegro | 39.6 |
7 | Denmark | 39.2 |
8 | United States of America | 38.4 |
9 | Poland | 38.0 |
10 | Canada | 37.9 |
11 | The Netherlands | 37.2 |
12 | French Polynesia | 37.1 |
13 | Belgium | 36.8 |
14 | China | 36.1 |
15 | Armenia | 35.9 |
16 | France (metropolitan) | 35.0 |
17 | Guam | 34.7 |
17 | Turkey | 34.7 |
19 | Croatia | 34.3 |
20 | Slovenia | 33.9 |
Source: Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray, F. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available from:http://globocan.iarc.fr, accessed on 13/12/2013.
Men
- Hungary has the highest rate of lung cancer in 2012, followed by Armenia and FYR Macedonia.
- About 61 per cent of lung cancer cases occurred in less developed countries
- The highest incidence of lung cancer was in Europe and Northern America; and the lowest incidence in Africa and, Latin America and Caribbean.
Rank | Country | Age-Standardised Rate per 100,000 (World) |
---|---|---|
1 | Hungary | 76.6 |
2 | Armenia | 72.9 |
3 | FYR Macedonia | 71.3 |
4 | Serbia | 70.3 |
5 | Turkey | 63.9 |
6 | Montenegro | 62.4 |
7 | Poland | 60.5 |
8 | Kazakhstan | 59.2 |
9 | Romania | 58.8 |
10 | Korea, Democratic Republic of | 58.5 |
11 | Croatia | 58.2 |
12 | Latvia | 58.0 |
13 | New Caledonia | 57.0 |
14 | Belarus | 56.9 |
15 | Belgium | 56.6 |
16 | Lithuania | 55.4 |
17 | Slovenia | 53.8 |
18 | French Polynesia | 53.2 |
19 | China | 52.8 |
20 | Spain | 52.5 |
Source: Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray, F. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available from:http://globocan.iarc.fr, accessed on 13/12/2013.
Women
- Denmark had the highest rate of lung cancer in 2012, followed by Canada and United States of America.
- About 54 per cent of lung cancer cases occurred in less developed countries.
- The highest incidence of lung cancer was in Northern America and Oceania; and the lowest incidence in Africa and, Latin America and Caribbean.
Rank | Country | Age-Standardised Rate per 100,000 (World) |
---|---|---|
1 | Denmark | 37.6 |
2 | Canada | 34.4 |
3 | United States of America | 33.7 |
4 | Korea, Democratic Republic of | 33.4 |
5 | Hungary | 33.2 |
6 | The Netherlands | 31.6 |
7 | Iceland | 28.9 |
8 | Ireland | 27.4 |
9 | Norway | 26.1 |
10 | United Kingdom | 25.8 |
11 | Serbia | 23.9 |
12 | Cuba | 23.8 |
13 | New Caledonia | 23.6 |
14 | New Zealand | 23.2 |
15 | Guam | 22.7 |
16 | Brunei | 22.0 |
17 | Poland | 21.8 |
18 | Australia | 21.5 |
19 | French Polynesia | 21.1 |
20 | China | 20.7 |
Source: Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray, F. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available from:http://globocan.iarc.fr, accessed on 13/12/2013.